Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP)
Clinical trial NCT02329860 · COMPLETED
Trial details
- NCT number
- NCT02329860
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-26
- Primary completion
- 2017-12-15
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.